RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY : Impact Factor & More

eISSN: 2772-2708pISSN: 2772-2716

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Frequency Semi-annual
General Details
FrequencySemi-annual
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Check if your research matches the topics covered in RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY

What is the publishing frequency of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY? Faqs

RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY published with a Semi-annual frequency.

What is the eISSN & pISSN for RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY? Faqs

For RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY, eISSN is 2772-2708 and pISSN is 2772-2716.

Who is the publisher of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY? Faqs

BENTHAM SCIENCE PUBL LTD is the publisher of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY.